[Naftidrofuryl in patients with prosthetic femoral-popliteal bypass].
Noppeney
T
T
Kasprzak
P
P
Raithel
D
D
Hirche
H
H
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001807:Blood Vessel Prosthesis; D002986:Clinical Trials as Topic; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D005663:Furans / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009257:Nafronyl / Q000009:adverse effects / Q000627:therapeutic use*; D011138:Polytetrafluoroethylene; D011150:Popliteal Artery / Q000601:surgery*; D011897:Random Allocation
D005663:Furans; D009257:Nafronyl; D011138:Polytetrafluoroethylene; D001241:Aspirin
Uber den Einsatz von Naftidrofuryl bei Patienten mit femoro-poplitealem Kunststoff-Bypass.